KYNTRA BIO CEO Wettig Thane forfeited 209 shares at $8.55 per share. The transaction left him with 26,796 shares and represented about 0.8% of his prior holding, giving investors the disclosed scale of the Withholding against his ownership position.

Key Highlights

  • The transaction occurred on Sep. 6, 2026, under code F.
  • Wettig Thane’s reported ownership stood at 26,796 shares after the transaction.
  • The forfeiture represented about 0.8% of his prior shareholding.

KYNTRA BIO, INC. (NASDAQ: KYNB) CEO Wettig Thane forfeited 209 shares at $8.55 per share. Following the transaction, his reported ownership stood at 26,796 shares.

KYNTRA BIO Executive Ownership Details

The transaction occurred on Sep. 6, 2026, and carried transaction code F. The action covered 209 shares, and the filing reports $8.55 per share. Wettig Thane is identified as KYNTRA BIO’s CEO. The reported figures separate the transaction quantity, the per-share amount and the resulting ownership balance. The 209 shares refer to the forfeiture itself, while the $8.55 amount applies to each forfeited share. The 26,796-share figure applies after the transaction, rather than to the number of shares involved in it.

Forfeiture Measured Against Prior Holding

The reported 0.8% figure is measured against Wettig Thane’s prior shareholding. The disclosed ownership after the transaction was 26,796 shares, and the stated price was $8.55 per share. Transaction code F denotes shares withheld or delivered to cover taxes or an exercise price.